Methods, systems and devices for multiple single-cell capturing and processing using microfluidics
US-9304065-B2 · Apr 5, 2016 · US
US9708654B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9708654-B2 |
| Application number | US-201314407849-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 17, 2013 |
| Priority date | Jun 15, 2012 |
| Publication date | Jul 18, 2017 |
| Grant date | Jul 18, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure generally relates to sequencing two or more genes expressed in a single cell in a high-throughput manner. More particularly, the present disclosure relates to a method for high-throughput sequencing of pairs of transcripts co expressed in single cells (e.g., antibody VH and VL coding sequence) to determine pairs of polypeptide chains that comprise immune receptors.
Opening claim text (preview).
What is claimed is: 1. A method comprising: a) sequestering single cells and an mRNA capture agent into individual compartments; b) lysing the cells and collecting mRNA transcripts with the mRNA capture agent; c) isolating the mRNA from the compartments using the mRNA capture agent; d) performing reverse transcription followed by PCR amplification on the captured mRNA; and e) sequencing at least two distinct cDNA products amplified from a single cell, wherein: (i) the at least two distinct cDNA products comprise paired antibody VH and VL sequences, wherein the cells are B-cells; or (ii) the at least two distinct cDNA products comprise paired T-cell receptor sequences, wherein the cells are T-cells. 2. The method of claim 1 , wherein the at least two distinct cDNA products comprise paired antibody VH and VL sequences, wherein the cells are B-cells. 3. The method of claim 1 , wherein the mRNA capture agent is a bead. 4. The method of claim 3 , wherein the beads are magnetic. 5. The method of claim 3 , wherein the bead comprises oligonucleotides which hybridize mRNA. 6. The method of claim 5 , wherein the oligonucleotides comprise at least one of poly(T) and primers specific to a transcript of interest. 7. The method of claim 2 , wherein the paired antibody VH and VL sequences are for an antibody that binds to an antigen of interest. 8. The method of claim 5 , wherein the beads are conjugated to an antigen of interest and the oligonucleotides are only conjugated to the beads in the presence of an antibody that binds to the antigen of interest. 9. The method of claim 1 , wherein the individual compartments are wells in a gel or microtiter plate. 10. The method of claim 1 , said individual compartments having a volume of less than 5 nL. 11. The method of claim 10 , wherein the compartments are sealed with a permeable membrane prior to step (c). 12. The method of claim 1 , wherein the individual compartments are microvesicles in an emulsion. 13. The method of claim 1 , wherein steps (a) and (b) are performed concurrently. 14. The method of claim 1 , wherein steps (a) and (b) comprise isolating single cells and an mRNA capture agent into individual microvesicles in an emulsion and in the presence of a cell lysis solution. 15. The method of claim 2 , comprising obtaining sequences from at least 10,000 individual cells or at least 5,000 individual paired antibody VH and VL sequences. 16. The method of claim 1 , wherein step (e) comprises: linking VH and VL cDNAs by performing overlap extension reverse transcriptase polymerase chain reaction to link VH and VL cDNAs in single DNA molecules, wherein the at least two distinct cDNA products comprise paired antibody VH and VL sequences. 17. The method of claim 1 , wherein step (e) does not comprise the use of overlap extension reverse transcriptase polymerase chain reaction. 18. The method of claim 2 , wherein the VH and VL sequences are obtained by sequencing of distinct molecules. 19. The method of claim 1 , wherein the at least two distinct cDNA products comprise paired T-cell receptor sequences, wherein the cells are T-cells. 20. The method of claim 1 , wherein step (e) comprises linking cDNA by performing overlap extension reverse transcriptase polymerase chain reaction to link at least 2 transcripts into a single DNA molecule.
Handling flowable solids, e.g. microscopic beads, cells, particles · CPC title
Methods for sequencing · CPC title
Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title
specially adapted for droplet or plug flow, e.g. digital microfluidics · CPC title
by coupling phenotype to genotype, not provided for in other groups of this subclass · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.